• 1
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. DSM-IV. Washington , DC : American Psychiatric Association; 1994.
  • 2
    Saper JR, Lake AE III. Borderline personality disorder and the chronic headache patient: Review and management recommendations. Headache. 2002;42:663-674.
  • 3
    Saper JR, Hamel RL, Lake AE III. Medication overuse headache (MOH) is a biobehavioral disorder. Cephalalgia. 2005;25:545-546.
  • 4
    Saper JR, Silberstein SD, Gordon CD, Hamel RL. Handbook of Headache Management. 2nd edition. Lippincott Williams and Wilkins, Baltimore ; 1992.
  • 5
    Lake AE III, Saper JR, Hamel RL. Inpatient treatment of intractable headache: Outcome for 267 consecutive program completers (abstract), 2006. Headache. 2006;46:893.
  • 6
    Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, et al Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder. An open label trial. J Clin Psychiatry. 1999;60:598-603.